OLD Category: pan cancer panels

Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer

• Fujiwara K, Saung MT, Jing H...Cheadle N, Koenitzer J, Zheng L

Tumor Microenvironment composition and severe cytokine release syndrome (CRS) Influence Toxicity in Patients with Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel

• Faramand R, Jain M, Staedtke V...Anasetti C, Locke FL, Davila ML

Lactate production by Staphylococcus aureus biofilm inhibits HDAC11 to reprogram the host immune response during persistent infection

• Heim CE, Bosch ME, Yamada KJ...Seto E, Karpf AR, Kielian T

Myocardial Infarction Accelerates Breast Cancer via Innate Immune Reprogramming

• Koelwyn GJ, Newman AAC, Afonso MS...Caan BJ, Jones LW, Moore KJ

Targeting the MAPK7/MMP9 axis for metastasis in primary bone cancer

• Green D, Eyre H, Singh A...Dalmay T, Fraser WD, Finegan KG

Colon-specific immune microenvironment regulates cancer progression versus rejection

• Trimaglio G, Tilkin-Mariamé AF, Feliu V...Vergnolle N, Rombouts Y, Devaud C

Intracellular Fate and Impact on Gene Expression of Doxorubicin/Cyclodextrin-Graphene Nanomaterials at Sub-Toxic Concentration

• Caccamo D, Curro M, Ientile R...Astilean S, Piperno A, Sciortino MT

Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model

• Philippou Y, Sjoberg HT, Murphy E...Hamdy FC, Muschel RJ, Bryant RJ

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

• Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D.

Impact of checkpoint blockade on cancer vaccine-activated CD8+ T cell responses

• Santos PM, Adamik J, Howes TR, Du S, Vujanovic L, Warren S, Gambotto A, Kirkwood JM, Butterfield LH

Association of Tumor Budding With Immune Evasion Pathways in Primary Colorectal Cancer and Patient-Derived Xenografts

• Guil-Luna S, Mena R, Navarrete-Sirvent C...De la Haba-Rodríguez JR, Aranda E, Rodríguez-Ariza A

Immunological Differences Between Immune-Rich Estrogen Receptor–Positive and Immune-Rich Triple-Negative Breast Cancers

• O’Meara T, Marczyk M, Qing T, Yaghoobi V, Blenman K, Cole K, Pelekanou V, Rimm DL, Pusztai L